Physician profile
Christopher Jm Brooks
NPI 1184694952
$7,532.38
in general payments reported to CMS, 2019-2025
19 companies · $1,453 in 2025
The $1,453 reported for 2025 was more than what 80% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $409 · 2021: $515 · 2022: $1,162 · 2023: $785 · 2024: $2,099 · 2025: $1,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,336.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,803.23 | 2019-2021 | |
| Tela Bio, INC. | $1,535.26 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $1,449.38 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Rti Surgical, INC | $517.44 | 2025 | |
| Sientra, INC. | $435.80 | 2022 | |
| Axonics, INC. | $362.02 | 2023-2024 | Axonics |
| Axogen | $206.81 | 2023-2024 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Musculoskeletal Transplant Foundation INC. | $206.67 | 2022-2025 | |
| Smith+Nephew, INC. | $200.90 | 2024-2025 | Pico 14, Renasys Touch |
| Davol INC. | $197.21 | 2022-2025 | Phasix Mesh |
| Abbott Laboratories | $149.95 | 2023 | Aveir |
| Integra Lifesciences Corporation | $134.60 | 2022-2025 | Integra, Omnigraft, Surgimend |
| Solventum Corporation | $76.18 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Revance Therapeutics, INC. | $76.04 | 2025 | Daxxify |
| Kerecis Limited | $57.97 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $44.11 | 2025 | Onetrac Lx |
| Biotissue Holdings INC. | $35.48 | 2025 | |
| Motiva USA, LLC | $25.12 | 2024 | |
| Innovation Technologies INC | $18.21 | 2023 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.